Wagner, S N <br/><br/>
Analysis of Pmel17/gp100 expression in primary human tissue specimens: implications for melanoma immuno- and gene-therapy.  [electronic resource] 

 -  Cancer immunology, immunotherapy : CII  Jun 1997 
 - 239-47 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0340-7004 
<br/><br/><label>Standard No.: </label>10.1007/s002620050379  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Neoplasm--analysis<br/>Antigens, Neoplasm<br/>Antigens, Tumor-Associated, Carbohydrate--analysis<br/>Blotting, Northern<br/>Gene Expression Regulation, Neoplastic<br/>Genetic Therapy--methods<br/>Humans<br/>Immunohistochemistry<br/>Immunophenotyping<br/>Immunotherapy--methods<br/>In Situ Hybridization<br/>Melanoma--immunology<br/>Melanoma-Specific Antigens<br/>Membrane Glycoproteins<br/>Neoplasm Proteins--analysis<br/>Nevus--immunology<br/>Proteins<br/>RNA, Messenger--analysis<br/>Sensitivity and Specificity<br/>Skin Neoplasms--immunology<br/>T-Lymphocytes, Cytotoxic--immunology<br/>Transcription, Genetic<br/>Tumor Cells, Cultured<br/>Uveal Neoplasms--immunology<br/>gp100 Melanoma Antigen